Newsletter | November 15, 2022

11.15.22 -- Optimize Clinical Trial Outcomes With The Patient Voice In Mind

Meeting Patients Where They Are With Technology

This video, featuring Jeff Spaeder, chief medical officer from IQVIA, discusses how technology is an enabler to making trials more patient-centric, which helps the industry meet patients where they are.

Patient-Centricity By Design

In making the transition to decentralized clinical trials (DCTs), explore ways to gather insights into patient preferences and needs and apply them to the design and delivery phases of a study to drive efficiency and improved patient engagement.

Planning For Diversity

Efforts to make clinical trials more diverse received a potentially game-changing boost from the U.S. Food and Drug Administration (FDA). In this blog, find out more about the new FDA guidance on diversity in clinical trials, with a clear focus on up-front planning and goal setting earlier in development.

Industry Experts Tackle DCT Barriers

The shift to technology-driven trials and specialized care for study participants during the pandemic opened the industry’s eyes to the benefits of decentralized research models. Explore how choosing a DCT model can add value across treatment categories and patient populations.

Patient Recruitment And Enablement, Redefined

IQVIA Patient Recruitment and Enablement harnesses the power of IQVIA Connected Intelligence™ to offer modern solutions for patient-focused trials that accelerate enrollment, reduce site burden, and deliver trials on time and budget.

Request Information
Speed Your Clinical Trial By Transforming Your Patient Recruitment

Patient recruitment remains a significant challenge for researchers. IQVIA Direct-to-Patient Recruitment offers a recruitment strategy that eliminates obstacles that add time, cost, and uncertainty to current recruiting efforts.

Request Information